Helicos, ein interessanter BioSc.-Wert? WKN:A0MSNB
Seite 1 von 1 Neuester Beitrag: 17.06.10 17:14 | ||||
Eröffnet am: | 11.08.09 22:40 | von: Cyberkunde | Anzahl Beiträge: | 9 |
Neuester Beitrag: | 17.06.10 17:14 | von: Chalifmann3 | Leser gesamt: | 3.127 |
Forum: | Hot-Stocks | Leser heute: | 7 | |
Bewertet mit: | ||||
hab mal ein wenig recherchiert... geht um folgendes:
HELICOS BIOSCIENCES CORP. hat eine Maschine mit dem Namen Helicos Biosciences SMS Heliscope erfolgreich getestet. Mit dieser Maschine werden die Kosten einer Entschlüsslung des genetischen Codes massiv gesenkt.
Eine entsprechende Pressemeldung folgte, ein Bericht auf den medizinischen Seite der Stanford University folgte am folgenden Tag.
Für mich ein interessanter Wert, scheinen doch die Zukunftsperspektiven hier zu stimmen...
Was meint ihr?
http://med.stanford.edu/ism/2009/august/genome.html
"... This is the first demonstration that you don’t need a genome center to sequence a human genome,” said Stephen Quake, PhD, professor of bioengineering. “It’s really democratizing the fruits of the genome revolution and saying that anybody can play in this game ... "
"... To sequence his genome, Quake’s team used a commercially available, refrigerator-sized instrument called the Helicos Biosciences SMS Heliscope. Quake, who pioneered the underlying technology in 2003, is a co-founder of the Cambridge, Mass.-based company and chairs its scientific advisory board ... "
http://ir.helicosbio.com/releasedetail.cfm?ReleaseID=402502
-ý IR-Site mit entsprechender Pressemeldung
http://www.youtube.com/watch?v=TboL7wODBj4
-ý nette gemachtes 3D Video zum Helicos Biosciences SMS Heliscope
http://www.google.com/finance?q=NASDAQ:HLCS
-ý Link zum REAL TIME Charts..
Das war´s an interessanten sachen, die ich finden konnte...
Freu mich auf euer Feedback & Meinungen zum möglchen investement...
Daraus könnte man jetzt den Schluss ziehen (wenn man nicht vom Fach ist),dass Helicos hier massiv vorschusslorbeeren bekommt,sehe ich das falsch... ?
MFg
Chali
Leaders in the field of cancer genomics to leverage benefits of single molecule sequencing technology
Press Release
Source: Helicos BioSciences Corporation
On Thursday August 20, 2009, 7:30 am EDT
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences Corporation (NASDAQ: HLCS - News), a life science company focused on innovative genetic analysis technologies, today announced the placement of a Helicos™ Genetic Analysis System at the Ontario Institute for Cancer Research (OICR) with Drs. Tom Hudson and John McPherson.
“We are very excited to be working with such a distinguished institution on the application of our technology to the study of cancer genomics” stated Ron Lowy, Helicos Chief Executive Officer.
The Helicos Genetic Analysis System is the world’s first and only commercially available, single molecule sequencing technology, and enables scientists to conduct revolutionary studies in the fields of genome biology, cancer research, common diseases, and microbiology without DNA ligation or amplification. Genetic analysis with Helicos’s technology eliminates the biases, complexity and errors introduced by DNA amplification, requires minute amounts of starting material, and provides the most direct and accurate view of biological samples.
“The translational cancer research we are conducting at our center can benefit greatly from the advantages of single molecule sequencing” stated Tom Hudson, President and Scientific Director of the OICR. “We hope to use this technology for the unbiased and comprehensive characterization of tumor samples to ultimately lead to discoveries that have a clinical impact.”
MFG
Chali
MFG
Chali